Intuitive Surgical, Inc. (NASDAQ:ISRG – Get Free Report) EVP Mark Brosius sold 46 shares of the company’s stock in a transaction dated Monday, November 16th. The shares were sold at an average price of $444.38, for a total value of $20,441.48. Following the completion of the sale, the executive vice president directly owned 411 shares of the company’s stock, valued at approximately $182,640.18. This trade represents a 10.07% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
Mark Brosius also recently made the following trade(s):
- On Wednesday, November 18th, Mark Brosius sold 46 shares of Intuitive Surgical stock. The stock was sold at an average price of $430.63, for a total value of $19,808.98.
- On Wednesday, October 28th, Mark Brosius sold 61 shares of Intuitive Surgical stock. The stock was sold at an average price of $441.60, for a total value of $26,937.60.
- On Monday, October 26th, Mark Brosius sold 61 shares of Intuitive Surgical stock. The stock was sold at an average price of $451.75, for a total value of $27,556.75.
- On Friday, September 11th, Mark Brosius sold 25 shares of Intuitive Surgical stock. The shares were sold at an average price of $365.79, for a total value of $9,144.75.
- On Wednesday, September 9th, Mark Brosius sold 23 shares of Intuitive Surgical stock. The shares were sold at an average price of $350.20, for a total value of $8,054.60.
- On Tuesday, September 8th, Mark Brosius sold 46 shares of Intuitive Surgical stock. The stock was sold at an average price of $361.23, for a total transaction of $16,616.58.
- On Friday, August 21st, Mark Brosius sold 77 shares of Intuitive Surgical stock. The stock was sold at an average price of $375.57, for a total transaction of $28,918.89.
Intuitive Surgical Price Performance
Shares of Intuitive Surgical stock opened at $420.95 on Thursday. The firm’s fifty day simple moving average is $421.98 and its 200-day simple moving average is $428.75. Intuitive Surgical, Inc. has a 12 month low of $328.57 and a 12 month high of $603.88. The stock has a market capitalization of $145.92 billion, a price-to-earnings ratio of 50.90, a PEG ratio of 2.97 and a beta of 1.45.
Intuitive Surgical (NASDAQ:ISRG – Get Free Report) last issued its quarterly earnings results on Tuesday, October 20th. The medical equipment provider reported $3.00 earnings per share for the quarter, topping analysts’ consensus estimates of $2.65 by $0.35. Intuitive Surgical had a net margin of 25.54% and a return on equity of 18.17%. The firm had revenue of $3.05 billion during the quarter, compared to analysts’ expectations of $2.91 billion. During the same quarter in the prior year, the business earned $2.40 EPS. Intuitive Surgical’s quarterly revenue was up 21.7% compared to the same quarter last year. Analysts anticipate that Intuitive Surgical, Inc. will post 9.37 earnings per share for the current year.
Wall Street Analyst Weigh In
Several equities research analysts have recently weighed in on ISRG shares. Sanford C. Bernstein reiterated an “outperform” rating on shares of Intuitive Surgical in a research note on Wednesday, August 12th. Wall Street Zen upgraded Intuitive Surgical from a “hold” rating to a “buy” rating in a research report on Saturday, October 31st. TD Cowen reaffirmed a “buy” rating and set a $485.00 price objective on shares of Intuitive Surgical in a research note on Monday, October 19th. JPMorgan Chase & Co. increased their price objective on Intuitive Surgical from $450.00 to $475.00 and gave the stock an “overweight” rating in a research report on Wednesday, October 21st. Finally, Leerink Partners set a $503.00 price target on shares of Intuitive Surgical and gave the stock an “outperform” rating in a research note on Wednesday, October 21st. One investment analyst has rated the stock with a Strong Buy rating, twenty-three have given a Buy rating, five have assigned a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat, Intuitive Surgical currently has an average rating of “Moderate Buy” and a consensus price target of $495.90.
Get Our Latest Analysis on ISRG
Hedge Funds Weigh In On Intuitive Surgical
Several large investors have recently added to or reduced their stakes in the business. Fi3 FINANCIAL ADVISORS LLC boosted its position in Intuitive Surgical by 19.1% during the 3rd quarter. Fi3 FINANCIAL ADVISORS LLC now owns 1,002 shares of the medical equipment provider’s stock worth $407,000 after purchasing an additional 161 shares during the period. Heartland Bank & Trust Co increased its holdings in Intuitive Surgical by 4.7% in the 3rd quarter. Heartland Bank & Trust Co now owns 2,082 shares of the medical equipment provider’s stock valued at $847,000 after purchasing an additional 94 shares in the last quarter. Harbor Advisors LLC purchased a new position in Intuitive Surgical in the third quarter valued at about $203,000. Innovator Capital Management LLC purchased a new position in Intuitive Surgical in the third quarter valued at about $7,982,000. Finally, Brown Financial Advisors lifted its stake in shares of Intuitive Surgical by 25.5% during the third quarter. Brown Financial Advisors now owns 2,877 shares of the medical equipment provider’s stock worth $1,170,000 after purchasing an additional 584 shares in the last quarter. 83.64% of the stock is currently owned by hedge funds and other institutional investors.
More Intuitive Surgical News
Investors following ISRG have been watching these news items:
- Positive Sentiment: Recent coverage highlights adjusted EPS growth of 25%, supported by robotic-platform adoption and AI-related innovation. This suggests strong demand and continued earnings growth, though higher R&D costs and a litigation settlement are offsets. ISRG EPS and innovation article
- Neutral Sentiment: EVP Mark Brosius reported sales totaling 92 shares across two transactions, worth about $40,250. Both were made under a pre-arranged Rule 10b5-1 plan, and the small size makes them a limited signal about management’s view of the stock. SEC insider-trading filing
- Negative Sentiment: A valuation-focused analysis argues ISRG may be near fair value despite revenue growth, pointing to competitive pressure and new robotic platforms. That may temper enthusiasm for the shares after their longer-term gains. Valuation and competition analysis
Intuitive Surgical Company Profile
Intuitive Surgical develops, manufactures and markets robotic-assisted systems for minimally invasive procedures. Its products include da Vinci surgical systems, which allow surgeons to control instruments and a high-definition vision system from a console, as well as the Ion endoluminal system, designed to assist with minimally invasive lung biopsies. The company also provides instruments, accessories, training and support services for its systems. Its technology is used in a range of surgical specialties, including urology, general surgery and gynecology.
Featured Stories
- Five stocks we like better than Intuitive Surgical
- Amazon’s Zoox Just Joined Uber—Could That Change the Robotaxi Threat?
- Drilling for Yield in the Gulf: Chevron Drops Anchor in Deepwater
- TJX Stock Flashes a Strong Bullish Signal as Its $3 Billion Buyback Plan Takes Shape
- Viking’s Low-Water Miss Looks Like a Buy-the-Dip Opportunity
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.
